Emergent BioSolutions scores nod for longer-lasting opioid overdose drug
August 17, 2020 at 14:53 PM EDT
The new product comes about five years after the FDA approved its original Narcan nasal spray.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|